@article{d666d01542954be0b0309791a2617820,
title = "Targeting senescence",
abstract = "Targeting senescent cells with repurposed FDA-approved drugs improves phenotypes of aging in mice.",
author = "Manuel Serrano and Nir Barzilai",
note = "Funding Information: M.S. was funded by the Institute for Research in Biomedicine (IRB–Barcelona), by the “la Caixa” Foundation, by grants from the Spanish Ministry of Economy (cofunded by the European Regional Development Fund) and by the European Research Council (from the European Union{\textquoteright}s Horizon 2020 research and innovation programme). The IRB–Barcelona is recipient of a Severo Ochoa Award of Excellence from the Spanish Ministry of Economy. N.B. is the recipient of grants from the National Institutes of Health (P01AG021654), the Nathan Shock Center of Excellence for the Biology of Aging (P30AG038072) and the Glenn Center for the Biology of Human Aging (Paul Glenn Foundation for Medical Research). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publisher Copyright: {\textcopyright} 2018, The Publisher.",
year = "2018",
month = aug,
day = "1",
doi = "10.1038/s41591-018-0141-4",
language = "English (US)",
volume = "24",
pages = "1092--1094",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "8",
}